These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 9619053)
1. [Cytogenetic analysis of hypophyseal adenoma. Study of 9 cases and review of the literature]. Buonamici L; Roncaroli F; Frank G; Dal Cin P; Van den Berghe H; Calbucci F; Eusebi V Pathologica; 1998 Apr; 90(2):116-9. PubMed ID: 9619053 [TBL] [Abstract][Full Text] [Related]
2. Simple numerical chromosome aberrations in two pituitary adenomas. Dietrich CU; Pandis N; Bjerre P; Schrøder HD; Heim S Cancer Genet Cytogenet; 1993 Sep; 69(2):118-21. PubMed ID: 8402547 [TBL] [Abstract][Full Text] [Related]
3. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases. Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847 [TBL] [Abstract][Full Text] [Related]
4. Structure-function correlations of growth hormone or/and prolactin-producing pituitary adenomas: an in vitro study with the reverse hemolytic plaque assay. Thodou E; Kontogeorgos G; Kyrodimou E; Salla H; Ramyar L; Vamvassakis E; Piaditis G; Anagnostopoulos N; Tzanis S; Levedis A; Rologis D; Asa SL J Endocrinol Invest; 1999 Oct; 22(9):671-80. PubMed ID: 10595830 [TBL] [Abstract][Full Text] [Related]
5. Effect of vasoactive intestinal polypeptide (VIP) on growth hormone (GH) and prolactin (PRL) release and cell morphology in human pituitary adenoma cell cultures. Fazekas I; Bácsy E; Varga I; Slowik F; Bálint K; Pásztor E; Czirják S; Gláz E Folia Histochem Cytobiol; 2000; 38(3):119-27. PubMed ID: 10970071 [TBL] [Abstract][Full Text] [Related]
6. Tissue kallikrein and the effect of bromocriptine in human prolactin and growth hormone-secreting pituitary adenomas. Jones TH; Figueroa CD; Smith CM; Bhoola KD Agents Actions Suppl; 1992; 38 ( Pt 2)():175-82. PubMed ID: 1462825 [TBL] [Abstract][Full Text] [Related]
8. Cortistatin inhibits growth hormone release from human fetal and adenoma pituitary cells and prolactin secretion from cultured prolactinomas. Rubinfeld H; Hadani M; Barkai G; Taylor JE; Culler MD; Shimon I J Clin Endocrinol Metab; 2006 Jun; 91(6):2257-63. PubMed ID: 16595604 [TBL] [Abstract][Full Text] [Related]
9. [A rare case of polyhormonal hypophyseal adenoma]. Aruzmetova DS; Makhmudov EA Probl Endokrinol (Mosk); 1989; 35(5):54-5. PubMed ID: 2555816 [No Abstract] [Full Text] [Related]
10. Cytogenetic study of pituitary adenomas. Bettio D; Rizzi N; Giardino D; Persani L; Pecori-Giraldi F; Losa M; Larizza L Cancer Genet Cytogenet; 1997 Oct; 98(2):131-6. PubMed ID: 9332478 [TBL] [Abstract][Full Text] [Related]
11. Examination of the relationship between chromosome abnormality in pituitary adenomas and tumor invasiveness by normal karyotype analysis and interphase fluorescence staining. Gao H; Wang Q; Wu S; Hui G Med Oncol; 2012 Dec; 29(5):3462-6. PubMed ID: 22772969 [TBL] [Abstract][Full Text] [Related]
12. Long-term Outcome After Fractionated Radiotherapy for Pituitary Adenoma: The Curse of the Secretory Tumor. Scheick S; Amdur RJ; Kirwan JM; Morris CG; Mendenhall WM; Roper S; Friedman W Am J Clin Oncol; 2016 Feb; 39(1):49-54. PubMed ID: 25007040 [TBL] [Abstract][Full Text] [Related]
13. [Pituitary adenoma calcification]. Kurisaka M; Mori K; Tindall GT; Takei Y No To Shinkei; 1986 Dec; 38(12):1187-95. PubMed ID: 3028453 [TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic study of 123 cases of prolactin-secreting pituitary adenomas with special reference to multihormone production and clonality of the adenomas. Ma W; Ikeda H; Yoshimoto T Cancer; 2002 Jul; 95(2):258-66. PubMed ID: 12124824 [TBL] [Abstract][Full Text] [Related]
16. Subclinical adenomas in postmortem pituitaries: classification and correlations to clinical data. Buurman H; Saeger W Eur J Endocrinol; 2006 May; 154(5):753-8. PubMed ID: 16645024 [TBL] [Abstract][Full Text] [Related]
17. [The relationship between cell proliferation activity and secretory activity in pituitary adenoma--a review of 63 cases]. Asano K; Kubo O; Tajika Y; Huang MC; Takakura K No To Shinkei; 1996 Jun; 48(6):543-9. PubMed ID: 8703557 [TBL] [Abstract][Full Text] [Related]
18. The novel somatostatin analog SOM230 is a potent inhibitor of hormone release by growth hormone- and prolactin-secreting pituitary adenomas in vitro. Hofland LJ; van der Hoek J; van Koetsveld PM; de Herder WW; Waaijers M; Sprij-Mooij D; Bruns C; Weckbecker G; Feelders R; van der Lely AJ; Beckers A; Lamberts SW J Clin Endocrinol Metab; 2004 Apr; 89(4):1577-85. PubMed ID: 15070915 [TBL] [Abstract][Full Text] [Related]
19. Management of endocrine disease: clinicopathological classification and molecular markers of pituitary tumours for personalized therapeutic strategies. Raverot G; Jouanneau E; Trouillas J Eur J Endocrinol; 2014 Apr; 170(4):R121-32. PubMed ID: 24431196 [TBL] [Abstract][Full Text] [Related]
20. Chromosomal abnormalities in pituitary adenomas. Bello MJ; de Campos JM; Kusak ME; Vaquero J; Sarasa JL; Rey JA Cancer Genet Cytogenet; 2001 Jan; 124(1):76-9. PubMed ID: 11165326 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]